Federal National Mortgage Association
Change company Symbol lookup
Select an option...
FNMA Federal National Mortgage Association
MPW Medical Properties Trust Inc
PSXP Phillips 66 Partners LP
EQ Equillium Inc
TSLA Tesla Inc
OPK OPKO Health Inc
PNW Pinnacle West Capital Corp
ROLL RBC Bearings Inc
GLAD Gladstone Capital Corp
PAC Grupo Aeroportuario del Pacifico SAB de CV
Go

Financials : Thrifts & Mortgage Finance | Small Cap Value
Company profile

Federal National Mortgage Association is a government-sponsored enterprise chartered by Congress. The Company serves as a source of liquidity for purchases of homes and financing of multifamily rental housing, as well as for refinancing existing mortgages. It operates through two segments: Single-Family and Multifamily. Its Single-Family and Multifamily segments engage in business activities that provide liquidity to the mortgage market and manage the availability and affordability of housing in the United States. The Single-Family segment operates in the secondary mortgage market relating to loans secured by properties containing four or fewer residential dwelling units. The Multifamily segment operates in the secondary mortgage market relating primarily to loans secured by properties containing five or more residential units. The Company funds its business primarily through the issuance of short-term and long-term debt securities in the domestic and international capital markets.

Closing Price
$1.88
Day's Change
-0.05 (-2.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.93
Day's Low
1.87
Volume
(Heavy Day)
Volume:
2,061,541

10-day average volume:
1,659,612
2,061,541

UPDATE: Clorox and P&G struggle to meet COVID-19-related spike in demand

4:06 pm ET August 5, 2020 (MarketWatch)
Print

By Tonya Garcia, MarketWatch

Clorox shares have soared more than 54% for the year to date

Clorox Co. and Proctor & Gamble Co. have seen sales for their hygienic and cleaning products skyrocket during the COVID-19 pandemic, with both consumer goods giants struggling to keep up with demand.

Clorox Co. (CLX) reported fiscal fourth-quarter (http://www.marketwatch.com/story/cloroxs-stock-rallies-after-profit-and-sales-beats-as-sales-of-cleaning-products-provides-a-boost-2020-08-03) profit and sales that beat expectations, with cleaning products a highlight of the quarter. Cleaning, which includes the laundry and home care categories, accounted for 30% of fiscal year 2020 sales.

"The business had another quarter of double-digit sales growth behind continued elevated demand across the portfolio," said Lisah Burhan, vice president of investor relations, on the earnings call, according to a FactSet transcript.

"While we've been able to add significant capacity, demand still far exceeds supply, leading to continued out-of-stocks for many products."

Read:The back-to-school shopping season will be a 'dud,' one analyst says, but the NRF is forecasting a record breaker (http://www.marketwatch.com/story/the-back-to-school-shopping-season-will-be-a-dud-one-analyst-says-but-the-nrf-is-forecasting-a-record-breaker-2020-07-15)

According to reports (https://finance.yahoo.com/news/clorox-wont-enough-disinfecting-wipes-110000067.html), one of those products is Clorox Wipes, which might not be fully stocked on store shelves until next year.

MarketWatch reached out to Clorox for details about availability of Clorox Wipes and received a statement that reiterates Chief Executive Benno Dorer's comments, from the earnings call.

"Since Q3, we were able to bring on more than 10 new suppliers to help us maximize our output, not just for disinfecting products, but for other parts of our portfolio too," he said, according to FactSet. "For disinfecting products, we're continuing to run our plants 24/7, and we'll be bringing more disinfecting capacity online in the midterm. With all the levers we're pulling to expand output, I am confident in our ability to do better for our customers and consumers."

Clorox stock has soared 54.5% for the year to date, with the stock up 16.6% in the past three months.

"Clorox continues to chase demand for disinfecting products and is still prioritizing shipments to healthcare facilities, which has caused some stock-outs on retail shelves and therefore share losses," wrote Linda Bolton Weiser, D.A. Davidson senior research analyst.

D.A. Davidson rates Clorox stock buy with a $269 price target.

P&G (PG) also beat on both profit and sales during its fiscal fourth quarter, with Chief Executive David Taylor saying on the earnings call last Thursday that many of the company's facilities are "running around the clock to deliver P&G products during this period of increased demand."

See: Target talks Christmas in July with holiday shopping announcement (http://www.marketwatch.com/story/target-talks-christmas-in-july-with-holiday-shopping-announcement-2020-07-27)

Just in time for the pandemic, P&G launched Microban 24, a sanitizing spray that promises to prevent the growth and spread of bacteria for 24 hours.

"In terms of capacity, there are areas like our Microban launch that went out in February that we are capacity-constrained now because we launched right as [coronavirus] was hitting, unbeknownst to us, and the demand spiked," said Taylor.

"Today, the run rate is now in the couple hundred million dollar range, which is more than we expected at the time we launched."

The company is also working to get inventory for Swiffer and dish soap products, which includes Dawn, back up after a sharp rise in demand, Taylor said. The company hasn't accomplished that just yet.

"And as of through this July, we have not seen the demand slow down very much yet in the home care area, which, to me, bodes well for the year."

JPMorgan rates P&G stock overweight with a $143 price target.

Don't miss:Amazon is making gains with older consumers as more people turn to e-commerce during COVID-19 (http://www.marketwatch.com/story/amazon-is-making-gains-with-older-consumers-as-more-people-turn-to-e-commerce-during-covid-19-2020-07-31)

"With momentum behind both pricing and volumes, we believe P&G can still generate mid-single-digit-plus organic sales growth in 2020 despite the challenges presented by COVID-19," analysts wrote.

"We expect P&G to leverage its improving top-line throughout its P&L, as we believe P&G will be able to drive operating leverage throughout the business (as it has done in the past) and unlock additional cost savings from its productivity programs."

P&G stock has gained 6.8% for the year to date, and has rallied 15% over the past three months.

The Dow Jones Industrial Average is down 4.7% for 2020 so far.

-Tonya Garcia; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 05, 2020 16:06 ET (20:06 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.